GSDMD and metabolic dysfunction-associated steatohepatitis: Cleavage of GSDMD promotes IL-1β release without affecting its maturation, and it indirectly activates NF-ĸB signalling pathway and the subsequent recruitment of hepatic macrophages for inflammatory development, thereby affecting NASH [37,38].